Furthermore, BANCR/TSHR signaling overexpression can significantly inhibit the luteolin antitumor impacts on thyroid cancer in vivo and in vitro and, as a result, can act as an essential anticancer agent for thyroid cancer through suppressing the BANCR/TSHR pathway [151]. The gene discussed is TSHR; the disease is thyroid gland carcinoma.